One Millionth Person Seeking to Quit Tobacco Contacts National Jewish Health
The National Jewish Health QuitLogix tobacco-cessation program reached a major milestone in mid-January, when it was contacted by the one millionth person interested in its quitline services. National Jewish Health is the largest nonprofit provider of tobacco-cessation services in the nation, serving 14 state quitlines and numerous businesses and health plans.
National Jewish Health to Provide Pediatric Respiratory, Allergy and Immunology Services at Rocky Mountain Hospital for Children at Presbyterian/St Luke’s Medical Center
National Jewish Health and Rocky Mountain Hospital for Children at Presbyterian/St. Luke’s Medical Center have announced an agreement for National Jewish Health for kids to provide diagnostic and treatment services for children with respiratory, allergic and immune system disorders.
National Jewish Health and ProPatient Collaborate to take Cystic Fibrosis Education to the Next Level
ProPatient is working with National Jewish Health to bring a novel new approach to educate and support CF patients. The program uses online simulations of health care providers to provide an interactive, conversation-based method of educating patients about cystic fibrosis and related health issues.
National Jewish Health Wins Contracts for Three State Quitlines
National Jewish Health has won awards to operate smoking-cessation quitlines for three new states: Massachusetts, Rhode Island and New Hampshire. National Jewish Health, the nation’s leading respiratory hospital, is the largest nonprofit provider of smoking-cessation services in the nation, with its QuitLogix tobacco-cessation programs now serving 14 states and numerous businesses and health plans, available to approximately 63 million people.
Study Links The Liquid Used In E-cigarettes To An Increased Risk Of Viral Infections
The liquid used in electronic cigarettes has been linked to a significantly higher risk of respiratory viral infections, whether the liquid contains nicotine or not, according to a published study by researchers at National Jewish Health in Denver.